Turn Therapeutics (TTRX) Total Liabilities (2024 - 2026)

Turn Therapeutics' Total Liabilities history runs 3 years deep, the most recent figure standing at $12.5 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 1630.04% year-over-year to $12.5 million; the TTM figure through Mar 2026 stood at $12.5 million (up 1630.04% YoY), while the FY2025 annual figure was $7.5 million, up 235.78% from the prior year.
• Total Liabilities was $12.5 million for Q1 2026 at Turn Therapeutics, up from $7.5 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $12.5 million in Q1 2026 to a low of -$818710.0 in Q1 2025.
• Historically, Total Liabilities has averaged $4.3 million across 3 years, with a median of $3.0 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Total Liabilities surged 235.78% in 2025, then jumped 1630.04% in 2026.
• A 3-year view of Total Liabilities shows it stood at $2.2 million in 2024, then soared by 235.78% to $7.5 million in 2025, then soared by 67.57% to $12.5 million in 2026.
• The last three Total Liabilities figures came in at $12.5 million (Q1 2026), $7.5 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.